Tecentriq-Avastin Combo Keeps Advanced Kidney Cancer in Check, Roche Says
News
Treatment with Tecentriq (atezolizumab) and Avastin (bevacizumab) reduces the risk that advanced kidney cancer patients’ disease will get worse, concludes a Phase 3 study by Roche. The Swiss pharma giant ... Read more